Bessemer Venture Partners Unveils New Seed Stage Fund To Invest In AI-Driven Technologies For Health Care

Venture capital firm Bessemer Venture Partners (Bessemer) recently announced the launch of a $10 million seed stage fund for investment in artificial intelligence (AI) driven technologies in the health care industry. The fund, titled The Deep Health Seed Program, is being led by Stephen Kraus and Adam Fisher, both partners of the company.

The Deep Health Seed Program will invest $100,000 to $2 million in the companies that it selects, beginning with Subtle Medical, a company that creates AI applications for radiology images. The new program follows an earlier investment this year by Bessemer into Qventus, a company that . . .